Protein Cage Nanoparticles as Delivery Nanoplatforms.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Biochemistry

Background:

• Protein cage nanoparticles are naturally occurring, protein-based nanostructures with defined cage-like architectures.
• They consist of multiple identical subunits, resulting in uniform size and symmetric structures.
• These nanoparticles exhibit genetic and chemical plasticity, allowing for tailored modifications.

Purpose of the Study:

• To explore the potential of protein cage nanoparticles as versatile delivery nanoplatforms.
• To highlight their utility in biomedical applications for diagnostics and therapeutics.
• To introduce them as a new paradigm for in vivo delivery systems.

Main Methods:

• Review and synthesis of existing research on various protein cage nanoparticles (e.g., ferritin, lumazine synthase, encapsulin, virus-like particles).
• Analysis of their structural and functional properties relevant to drug delivery.
• Evaluation of their biocompatibility and amenability to modification.

Main Results:

• Protein cage nanoparticles demonstrate significant potential as nanocarriers for simultaneous delivery of targeting ligands, diagnostic, and therapeutic agents.
• Examples like ferritin, lumazine synthase, encapsulin, and virus-like particles have been extensively studied and utilized.
• Their inherent biocompatibility and plasticity enable versatile applications in biomedical fields.

Conclusions:

• Protein cage nanoparticles represent highly biocompatible and adaptable platforms for in vivo delivery systems.
• Their unique structure and modifiability offer a new paradigm for developing simple yet versatile diagnostic and therapeutic nanoplatforms.
• Further exploration promises advanced applications in precision medicine.